The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis

Genes Chromosomes and Cancer

Volumn 49, Issue 9, 2010, Pages 844-850

  Kim, Sung Yong ^a   Lee, Jong Wook ^b   Lee, Sung Eun ^b   Cho, Byung Sik ^b   Kim, Myungshin ^c   Eom, Ki Seong ^b   Kim, Yoo Jin ^b   Kim, Hee Je ^b   Lee, Seok ^b   Min, Chang Ki ^b   Cho, Seok Goo ^b   Kim, Dong Wook ^b   Han, Kyungja ^c   Min, Woo Sung ^b  

^a Konkuk University Hospital   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CANCER SURVIVAL; CHROMOSOME 1Q; CHROMOSOME 7Q; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; TRISOMY 8; VIRUS HEPATITIS; ANEMIA, APLASTIC; CELL TRANSFORMATION; CHROMOSOME ABERRATION; GENETICS; KARYOTYPING; MIDDLE AGED; SURVIVAL RATE; TRISOMY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KARYOTYPING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; TRISOMY; YOUNG ADULT;

EID: 77955477205     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20793     Document Type: Article

References (15)

1. Appelbaum FR, Barrall J, Storb R, Ramberg R, Doney K, Sale GE, Thomas ED. 1987. Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol 15:1134-1139.
2. Bennett JM, Orazi A. 2009. Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: Recommendations for a standardized approach. Haematologica 94:264-268.
3. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R. 1976. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 48:63-70.
4. Gooley TA, Leisenring W, Crowley J, Storer BE. 1999. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706.
5. Gupta V, Brooker C, Tooze JA, Yi QL, Sage D, Turner D, Kangasabapathy P, Marsh JC. 2006. Clinical relevance of cytogenetic abnormalities at diagnosis of acquired aplastic anaemia in adults. Br J Haematol 134:95-99.
6. Heimpel H, Heit W, Lambertenghi Deliliers G, Polliack A, Parsells Kelly J. 1987. Incidence of aplastic anemia: The relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. Blood 70:1718-1721.
7. Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS. 2002. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129-3135. (Pubitemid 34525289)
8. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AW, Yin AW. 2003. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123:782-801.
9. Mikhailova N, Sessarego M, Fugazza G, Caimo A, De Filippi S, van Lint MT, Bregante S, Valeriani A, Mordini N, Lamparelli T, Gualandi F, Occhini D, Bacigalupo A. 1996. Cytogenetic abnormalities in patients with severe aplastic anemia. Haematologica 81:418-422.
10. Ohga S, Ohara A, Hibi S, Kojima S, Bessho F, Tsuchiya S, Ohshima Y, Yoshida N, Kashii Y, Nishimura S, Kawakami K, Nishikawa K, Tsukimoto I. 2002. Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis. Br J Haematol 118:313-319.
11. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G. 2005. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699-3709.
12. Reddy V, Khan S, Wingard JR, Mehta P. 1999. Treatment results in aplastic anemia trials need to be analyzed separately for pediatric and adult populations. Blood 94:1833-1834.
13. Scheinberg P, Wu CO, Nunez O, Young NS. 2009. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144:206-216.
14. Sugimori C, Chuhjo T, Feng X, Yamazaki H, Takami A, Teramura M, Mizoguchi H, Omine M, Nakao S. 2006. Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 107:1308-1314. (Pubitemid 43242363)
15. Sugimori C, Yamazaki H, Feng X, Mochizuki K, Kondo Y, Takami A, Chuhjo T, Kimura A, Teramura M, Mizoguchi H, Omine M, Nakao , S. 2007. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia. Exp Hematol 35:13-20.